These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11576212)
1. Topiramate for headaches. Evans RW; Young WB Headache; 2001 Sep; 41(8):833-5. PubMed ID: 11576212 [No Abstract] [Full Text] [Related]
2. Topiramate and the risk of urolithiasis. Hanchanale VS; Biyani CS; Browning AJ; Joyce AD BJU Int; 2011 Feb; 107(3):352-4. PubMed ID: 21265983 [No Abstract] [Full Text] [Related]
3. Topiramate and metabolic acidosis: an evolving story. Gupta S; Gao JJ; Emmett M; Fenves AZ Hosp Pract (1995); 2017 Dec; 45(5):192-195. PubMed ID: 28828886 [TBL] [Abstract][Full Text] [Related]
4. Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome. Palacio E; Rodero L; Pascual J Headache; 2004 May; 44(5):436-7. PubMed ID: 15147251 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Supuran CT; Di Fiore A; De Simone G Expert Opin Emerg Drugs; 2008 Jun; 13(2):383-92. PubMed ID: 18537527 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of topiramate in the prevention of childhood headaches. Hershey AD; Powers SW; Vockell AL; LeCates S; Kabbouche M Headache; 2002 Sep; 42(8):810-8. PubMed ID: 12390646 [TBL] [Abstract][Full Text] [Related]
7. [Potomania as a side-effect of topiramate]. Alda M; García Campayo J; Cerdán C; Laguna C Med Clin (Barc); 2007 Mar; 128(10):397-8. PubMed ID: 17386248 [No Abstract] [Full Text] [Related]
9. Topiramate and metabolic acidosis. Wilner A; Raymond K; Pollard R Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081 [TBL] [Abstract][Full Text] [Related]
10. Auditory hallucinations associated with topiramate. Matthews SC; Miller BP J Clin Psychiatry; 2001 Aug; 62(8):653. PubMed ID: 11561939 [No Abstract] [Full Text] [Related]
11. Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate. Shank RP; Smith-Swintosky VL; Maryanoff BE J Enzyme Inhib Med Chem; 2008 Apr; 23(2):271-6. PubMed ID: 18343915 [TBL] [Abstract][Full Text] [Related]
12. Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors. Mirza NS; Alfirevic A; Jorgensen A; Marson AG; Pirmohamed M Pharmacogenet Genomics; 2011 May; 21(5):297-302. PubMed ID: 21278619 [TBL] [Abstract][Full Text] [Related]
13. Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Supuran CT Expert Opin Drug Metab Toxicol; 2016; 12(4):423-31. PubMed ID: 26878088 [TBL] [Abstract][Full Text] [Related]
14. Topiramate and severe metabolic acidosis: case report. Burmeister JE; Pereira RR; Hartke EM; Kreuz M Arq Neuropsiquiatr; 2005 Jun; 63(2B):532-4. PubMed ID: 16059613 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904 [TBL] [Abstract][Full Text] [Related]